Bleomycin
Blenoxane (bleomycin) is a small molecule pharmaceutical. Bleomycin was first approved as Blenoxane on 1982-01-01. It is used to treat choriocarcinoma, hodgkin disease, melanoma, non-hodgkin lymphoma, and sarcoma amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Bleomycin sulfate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| BLENOXANE | Bristol Myers Squibb | N-050443 DISCN | 1982-01-01 | 2 products, RLD |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| bleomycin | unapproved drug for use in drug shortage | 2023-12-23 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| choriocarcinoma | — | D002822 | C58 |
| hodgkin disease | — | D006689 | C81 |
| melanoma | — | D008545 | — |
| non-hodgkin lymphoma | — | D008228 | C85.9 |
| sarcoma | — | D012509 | — |
| squamous cell carcinoma | — | D002294 | — |
| teratocarcinoma | — | D018243 | — |
| testicular neoplasms | — | D013736 | C62 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
Code | Description |
|---|---|
| J9040 | Injection, bleomycin sulfate, 15 units |
Clinical
Clinical Trials
197 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Kaposi sarcoma | D012514 | — | C46 | 3 | 2 | 3 | 1 | — | 9 |
| Head and neck neoplasms | D006258 | — | — | 1 | 2 | 3 | 1 | — | 7 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | — | 1 | 1 | 1 | 4 |
| Neoplasms | D009369 | — | C80 | — | — | 2 | 1 | — | 3 |
| Vomiting | D014839 | HP_0002013 | R11.1 | — | — | — | 1 | — | 1 |
| Nausea | D009325 | HP_0002018 | R11.0 | — | — | — | 1 | — | 1 |
| Hiv | D006678 | — | O98.7 | — | — | — | 1 | — | 1 |
| Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | — | — | — | 1 | — | 1 |
| Human herpesvirus 8 | D019288 | — | — | — | — | — | 1 | — | 1 |
| Warts | D014860 | — | B07 | — | — | — | 1 | — | 1 |
Show 2 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hodgkin disease | D006689 | — | C81 | 2 | 23 | 19 | — | 5 | 47 |
| Lymphoma | D008223 | — | C85.9 | 2 | 20 | 19 | — | 2 | 42 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 4 | 2 | 5 | — | 1 | 12 |
| Germ cell and embryonal neoplasms | D009373 | — | — | — | 3 | 5 | — | 2 | 10 |
| Teratoma | D013724 | — | D28 | — | 3 | 4 | — | — | 6 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | 1 | 3 | — | 1 | 5 |
| Uterine cervical neoplasms | D002583 | HP_0030159 | — | — | — | 2 | — | 1 | 3 |
| T-cell lymphoma peripheral | D016411 | — | — | — | 1 | 1 | — | — | 2 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | — | — | 2 | — | — | 2 |
| Cardiotoxicity | D066126 | EFO_1001482 | — | — | — | 2 | — | — | 2 |
Show 4 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Vascular malformations | D054079 | — | — | — | 1 | — | — | 2 | 3 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | — | 2 | — | — | — | 2 |
| Central nervous system neoplasms | D016543 | — | — | — | 1 | — | — | 1 | 2 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 2 | — | — | — | 2 |
| Urologic neoplasms | D014571 | — | C64-C68 | — | 1 | — | — | — | 1 |
| Urinary bladder neoplasms | D001749 | — | C67 | — | 1 | — | — | — | 1 |
| Plasma cell neoplasms | D054219 | — | — | — | 1 | — | — | — | 1 |
| Pneumocephalus | D011007 | EFO_1001398 | — | — | 1 | — | — | — | 1 |
| Sex cord-gonadal stromal tumors | D018312 | EFO_1000052 | — | — | 1 | — | — | — | 1 |
| Sertoli-leydig cell tumor | D018310 | — | — | — | 1 | — | — | — | 1 |
Show 7 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 2 | — | — | — | 1 | 3 |
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | 1 | — | — | — | 1 | 2 |
| Hemangioma | D006391 | — | D18.0 | 1 | — | — | — | 1 | 2 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 1 | — | — | — | — | 1 |
| Skin neoplasms | D012878 | EFO_0004198 | C44 | 1 | — | — | — | — | 1 |
| Melanoma | D008545 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Second primary neoplasms | D016609 | — | — | — | — | — | — | 1 | 1 |
| Esophageal neoplasms | D004938 | — | C15 | — | — | — | — | 1 | 1 |
| Esophageal diseases | D004935 | EFO_0009544 | K22.9 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Bleomycin |
| INN | bleomycin |
| Description | Bleomycin A2 is a bleomycin. It has a role as an antineoplastic agent and a metabolite. |
| Classification | Small molecule |
| Drug class | antibiotics (Streptomyces strain) |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1 |
Identifiers
| PDB | — |
| CAS-ID | 11056-06-7 |
| RxCUI | 1622 |
| ChEMBL ID | CHEMBL403664 |
| ChEBI ID | 3139 |
| PubChem CID | 5460769 |
| DrugBank | DB00290 |
| UNII ID | 40S1VHN69B (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 46,570 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
8,008 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use